Table 3.
Outcomes of SAVR According to Pre-Operative Risk Assessment
Low-risk (n=565) |
Intermediate- risk (n=309) |
High-risk (n=175) |
P value |
|
---|---|---|---|---|
Death at 30 days | 7 (1.2%) | 21 (6.8%) | 22 (12.6%) | <0.01 |
Estimated mortality | 2.3% | 5.5% | 14 % | <0.01 |
Observed/Expected (O/E) mortality | 0.52 | 1.23 | 0.9 | NA |
Stroke | 16 (2.8%) | 13 (4.2%) | 15 (8.6%) | 0.01 |
Myocardial infarction | 4 (0.7%) | 7 (2.3%) | 7 (4%) | 0.02 |
Reoperation for bleeding | 20 (3.5%) | 21 (6.8%) | 11 (6.3%) | 0.07 |
Renal failure | 5 (0.9%) | 4 (1.3%) | 6 (3.4%) | 0.07 |
Cardiac arrest | 8 (1.3%) | 12 (4.1%) | 14 (4.7%) | <0.01 |
Mechanical ventilation > 48 hours | 26 (4.6%) | 41 (13.3%) | 41 (23.4%) | <0.01 |
Tracheostomy | 0 (0%) | 3 (1.4%) | 3 (2.4%) | <0.01 |
Any complication | 8.6% | 24% | 33% | <0.01 |
Length of stay – mean (±SD) | 9 (6) | 15 (18) | 19 (15) | <0.01 |